News and Announcements
MD Anderson Leukaemia Expert Joins Prescient Therapeutics SAB
- Published November 27, 2015 3:34PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th November 2015, ASX Announcement
Cancer drug development company Prescient Therapeutics Ltd (ASX: PTX) is delighted to announce the appointment of an internationally regarded leukemia authority to its Scientific Advisory Board.
Professor Farhad Ravandi MD is based at the MD Anderson and Moffitt Cancer Center, which is one of the world’s most prestigious cancer institutions.
He currently holds position as Professor and Chief, Section of Developmental Therapeutics within the Department of Leukemia (AML) in early 2016.
Professor Ravandi is actively involved in clinical and translational research for the treatment of patients with various hematological malignancies, with a particular focus on leukemias.
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
